Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Mohammed A. Aleskandarany(Nottingham University Hospitals NHS Trust), Emad A. Rakha(Nottingham University Hospitals NHS Trust)
Cited by 126
Related Papers
Artificial intelligence in digital breast pathology: Techniques and applications
|The Breast|2019|200
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
|British Journal of Cancer|2016|125
Biological and clinical significance of PARP1 protein expression in breast cancer
|Breast Cancer Research and Treatment|2014|83
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
|British Journal of Cancer|2020|44